Article
Immunologic effects in patients with psoriatic arthritis treated with cyclosporine A.
The Journal of rheumatology - 1 Dec 1992
Boiardi L, Salvarani C, Macchioni P, Casadei Maldini M, Mancini R, Beltrandi E, Rossi F, Lodi L, Portioli I
Abstract excerpt
Twelve patients with psoriatic arthritis (PsA) and very active articular disease resistant to conventional second line therapy entered into a 6-month open study of cyclosporine A (CsA) at a starting dosage of 3 mg/kg/day. Comparisons of phenotypic characteristics of lymphocytes and response to mitogens of peripheral blood mononuclear cells (PBMC) were made between these patients with PsA before CsA therapy, 7...
Topics
- Antigens, CD
- Antigens, CD20
- Antigens, Differentiation, B-Lymphocyte
- Antigens, Differentiation, T-Lymphocyte
- Arthritis, Psoriatic
- CD3 Complex
- CD4-CD8 Ratio
- CD56 Antigen
- Cyclosporine
- HLA-DR Antigens